Xiamen bnct therapy receives patients in 2023. On February 4th, 20021year, Xiamen boron neutron capture therapy (BNCT) center was established. Since then, BNCT has been admitted to the hospital. 202 1 165438+ Chongqing Jingao Biotechnology Co., Ltd.1announced on October 23rd that the boron drug GJB0 1 has completed the research on raw materials and pharmaceutical preparations, and realized the pilot-scale mass production. This BPA boron drug is used for malignant tumors, such as melanoma, brain cancer and glioma. It is expected to be used in clinic in 2023.